dipyridamole has been researched along with Primary Peritonitis in 4 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study suggests that dipyridamole may have therapeutic potential in treating peritoneal fibrosis." | 7.71 | Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo. ( Fang, CC; Hsieh, BS; Hung, KY; Lee, PH; Shyu, RS; Tsai, CC; Tsai, TJ, 2001) |
| "This study suggests that dipyridamole may have therapeutic potential in treating peritoneal fibrosis." | 3.71 | Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo. ( Fang, CC; Hsieh, BS; Hung, KY; Lee, PH; Shyu, RS; Tsai, CC; Tsai, TJ, 2001) |
| "Chemical peritonitis was the dose-limiting toxicity." | 1.28 | Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole. ( Balis, FM; Cleary, SM; Goel, R; Horton, C; Howell, SB; Kirmani, S; Zimm, S, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caltik, A | 1 |
| Demircin, G | 1 |
| Bülbül, M | 1 |
| Erdogan, O | 1 |
| Akyüz, SG | 1 |
| Arda, N | 1 |
| Umgelter, A | 1 |
| Hung, KY | 1 |
| Shyu, RS | 1 |
| Fang, CC | 1 |
| Tsai, CC | 1 |
| Lee, PH | 1 |
| Tsai, TJ | 1 |
| Hsieh, BS | 1 |
| Goel, R | 1 |
| Cleary, SM | 1 |
| Horton, C | 1 |
| Balis, FM | 1 |
| Zimm, S | 1 |
| Kirmani, S | 1 |
| Howell, SB | 1 |
1 review available for dipyridamole and Primary Peritonitis
| Article | Year |
|---|---|
[Approach to the patient with zirrhotic ascites--no diagnosis without a tap].
Topics: Aminoglycosides; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; | 2010 |
3 other studies available for dipyridamole and Primary Peritonitis
| Article | Year |
|---|---|
An unusual case of ANA negative systemic lupus erythematosus presented with vasculitis, long-standing serositis and full-house nephropathy.
Topics: Administration, Oral; Adolescent; Antibodies, Antinuclear; Azathioprine; Cyclophosphamide; Dipyridam | 2013 |
Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo.
Topics: Animals; Cell Adhesion; Cell Division; Cells, Cultured; Collagen; Cyclic AMP; Dipyridamole; Disease | 2001 |
Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Dipyridamole; Dr | 1989 |